DUBLIN--(BUSINESS WIRE)--The "Global Medical Microbiology Testing Technologies Market (2022-2027) by Product, Method, Applications, End-user, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Medical Microbiology Testing Technologies Market is estimated to be USD 9.24 Bn in 2022 and is expected to reach USD 15.58 Bn by 2027, growing at a CAGR of 11.02%
Market Dynamics
Drivers
- Increasing Incidence of Infectious Diseases and Cancer
- Increased Funding for R&D and Technological Advancements in Rapid Microbiology Testing
Restraints
- The Stringent Regulations Related to Rapid Microbiology Testing Kits
Opportunities
- Technological Advancements in the Rapid Microbiology Testing Kits
- Increase in the Number of Research Activities for Microbiology Testing
Challenges
- High Capital Investments and Low Cost-benefit Ratio
Market Segmentations
The Global Medical Microbiology Testing Technologies Market is segmented based on Product, Method, Applications, End-user, and Geography.
- By Product, the market is classified into Consumables, Instruments, and Reagents and Kits.
- By Method, the market is classified into Cellular Component-based Rapid Microbiology Testing, Growth-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, ad Viability-based Rapid Microbiology Testing.
- By Applications, the market is classified into Clinical Disease Diagnostics, Cosmetics & Personal Care Products Testing, Environmental Testing, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, and Research Applications.
- By End-user, the market is classified into Academic Institutes, Contract Research Organizations, Cosmetics & Personal Care Testing Industry, Diagnostic Laboratories & Hospitals, Environmental Study Agencies, Food & Beverage Companies, Pharmaceutical & Biotechnology Companies, and Research Laboratories.
- By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Medical Microbiology Testing Technologies Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Medical Microbiology Testing Technologies Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Medical Microbiology Testing Technologies Market, By Product
7 Global Medical Microbiology Testing Technologies Market, By Method
8 Global Medical Microbiology Testing Technologies Market, By Applications
9 Global Medical Microbiology Testing Technologies Market, By End-user
10 Americas' Medical Microbiology Testing Technologies Market
11 Europe's Medical Microbiology Testing Technologies Market
12 Middle East and Africa's Medical Microbiology Testing Technologies Market
13 APAC's Medical Microbiology Testing Technologies Market
14 Competitive Landscape
15 Company Profiles
16 Appendix
16.1 Questionnaire
Companies Mentioned
- Abbott Laboratories, Inc.
- Bactest Ltd.
- Becton, Dickinson and Company
- Biomerieux SA
- Biosensia
- Bruker Corp.
- Charles River Laboratories International, Inc.
- Colifast
- Cordx
- Danaher Corp.
- Don Whitley Scientific, Ltd.
- Euroclone S.p.A
- Gradientech
- Lubioscience Gmbh
- Merck Kgaa
- Neogen Corp.
- Quidel Corp.
- r-biopharm Ag
- Rapid Micro Biosystems, Inc.
- Rqmicro Ag
- Sartorius Ag
- Serosep Ltd.
- Solus Scientific Solutions, Ltd.
- Thermo Fisher Scientific, Inc.
- Vivione Biosciences, LLC
For more information about this report visit https://www.researchandmarkets.com/r/n1eitn
